222 related articles for article (PubMed ID: 6291564)
1. Sustained haemodynamic and clinical effects of captopril in long-term treatment of severe chronic congestive heart failure.
Ricci S; Zaniol P; Teglio V; Baraldi P; Mattioli G
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):209S-215S. PubMed ID: 6291564
[TBL] [Abstract][Full Text] [Related]
2. A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response.
Chatterjee K; Parmley WW; Cohn JN; Levine TB; Awan NA; Mason DT; Faxon DP; Creager M; Gavras HP; Fouad FM
Am Heart J; 1985 Aug; 110(2):439-47. PubMed ID: 3895877
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment of congestive heart failure with captopril.
Komajda M; Eugene M; Evans J; Drobinski G; Laurenceau JL; Grosgogeat Y
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):223S-229S. PubMed ID: 6753904
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
[TBL] [Abstract][Full Text] [Related]
5. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.
Ader R; Chatterjee K; Ports T; Brundage B; Hiramatsu B; Parmley W
Circulation; 1980 May; 61(5):931-7. PubMed ID: 6244906
[TBL] [Abstract][Full Text] [Related]
6. [Clinical, haemodynamic and biochemical effects of angiotensin-converting enzyme inhibition in chronic refractory cardiac failure (author's transl)].
Kayanakis JG; Giraud P; Puel J; Cassagneau B; Sabot G; Fauvel JM; Bounhoure JP
Nouv Presse Med; 1981 Apr; 10(19):1583-6. PubMed ID: 6269558
[TBL] [Abstract][Full Text] [Related]
7. Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.
Romankiewicz JA; Brogden RN; Heel RC; Speight TM; Avery GS
Drugs; 1983 Jan; 25(1):6-40. PubMed ID: 6218982
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders.
Packer M; Medina N; Yushak M
Am J Cardiol; 1984 Oct; 54(7):771-7. PubMed ID: 6091434
[TBL] [Abstract][Full Text] [Related]
9. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.
Dzau VJ; Colucci WS; Williams GH; Curfman G; Meggs L; Hollenberg NK
N Engl J Med; 1980 Jun; 302(25):1373-9. PubMed ID: 6246425
[TBL] [Abstract][Full Text] [Related]
10. Clinical and haemodynamic effects of low dose captopril in severe chronic heart failure.
Sharpe DN; Coxon RJ
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):161S-167S. PubMed ID: 6753897
[TBL] [Abstract][Full Text] [Related]
11. The renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure. Effect of angiotensin I converting enzyme inhibitor SQ 14225 (Captopril).
Kubo S; Nishioka A; Nishimura H; Sonotani N; Takatsu T
Jpn Circ J; 1980 Jun; 44(6):427-37. PubMed ID: 6995635
[No Abstract] [Full Text] [Related]
12. Short and long-term effects of treatment with low dose captopril in patients with severe congestive heart failure.
Dahlström U; Karlberg BE
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):231S-235S. PubMed ID: 6753905
[TBL] [Abstract][Full Text] [Related]
13. Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure.
Kramer B; Topic N; Massie B
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):143S-151S. PubMed ID: 6753895
[No Abstract] [Full Text] [Related]
14. Haemodynamic and neurohumoral response to exercise in patients with congestive heart failure treated with captopril.
Creager MA; Faxon DP; Weiner DA; Ryan TJ
Br Heart J; 1985 Apr; 53(4):431-5. PubMed ID: 3885981
[TBL] [Abstract][Full Text] [Related]
15. Clinical and haemodynamic responses to captopril and hydralazine in chronic congestive heart failure: the importance of preload reduction.
Fitzgerald DJ; O'Callaghan WG; O'Malley K; Horgan J; O'Brien E
Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):217S-222S. PubMed ID: 6753903
[TBL] [Abstract][Full Text] [Related]
16. Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.
Levine TB; Franciosa JA; Cohn JN
Circulation; 1980 Jul; 62(1):35-41. PubMed ID: 6247102
[No Abstract] [Full Text] [Related]
17. Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure.
Packer M; Meller J; Medina N; Yushak M
Am J Cardiol; 1983 Jan; 51(1):183-8. PubMed ID: 6336876
[TBL] [Abstract][Full Text] [Related]
18. Effects of captopril in acute and chronic heart failure. Correlations with plasma levels of noradrenaline, renin, and aldosterone.
Wenting GJ; Man in't veld AJ; Woittiez AJ; Boomsma F; Laird-Meeter K; Simoons ML; Hugenholtz PG; Schalekamp MA
Br Heart J; 1983 Jan; 49(1):65-76. PubMed ID: 6336940
[TBL] [Abstract][Full Text] [Related]
19. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
Turini GA; Waeber B; Brunner HR
Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure.
Awan NA; Evenson MK; Needham KE; Win A; Mason DT
Am Heart J; 1981 Jan; 101(1):22-31. PubMed ID: 6257100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]